Clinical Trials Logo

Esophagitis clinical trials

View clinical trials related to Esophagitis.

Filter by:

NCT ID: NCT02320981 Completed - Clinical trials for Functional Dyspepsia

Mucosal Impedance in Pediatric Population

Start date: August 2014
Phase: N/A
Study type: Observational

Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.

NCT ID: NCT02314455 Terminated - Clinical trials for Eosinophilic Esophagitis

Esophageal Absorption in EoE

EoE
Start date: September 2014
Phase: N/A
Study type: Interventional

To determine how the esophagus in active and inactive stages of eosinophilic esophagitis tranmit fluids.

NCT ID: NCT02288728 Terminated - Quality of Life Clinical Trials

Double Tract Anastomosis and Gastric Tube Anastomosis to Proximal Gastrectomy

DTA&GTA
Start date: December 2014
Phase: N/A
Study type: Interventional

Gastric cancer as one of the most common gastrointestinal cancers, radical resection of primary lesions combined with dissection of regional lymph-nodes is acknowledged by surgeons all over the world. When compared with the advanced upper third gastric cancer, proximal gastrectomy has been acknowledged as the standard therapeutic strategy for the early gastric cancer located in the upper third of the stomach. However, due to abandon the anti-reflux barrier of the digestive system caused by the dissection of the cardia and the lower esophageal sphincter, the belching、hiccup、Acid reflux、heartburn、chest pain symptoms and as well as the reflux esophagitis caused by the traditional esophagostomy permanently influence the postoperative quality of life for those patients. Nowadays, relationship between the digestive track reconstruction for proximal gastrectomy and the postoperative quality of life is still with controversies. Previous study reported the gastric tube anastomosis can minimize the reflux related symptoms when compared with traditional esophagogastrostomy. There still exited some patients need long-term anti-acid drug to control the reflux symptoms although underwent the gastric tube anastomosis. The double-track anastomosis for proximal gastrectomy may successfully control the reflux symptoms and there existed study found it is as safe as the esophagostomy. But there has no randomized control study to compare the postoperative quality of life between the gastric tube anastomosis and double-track anastomosis for proximal gastrectomy. By the reasons above, a randomized controlled trial is conducted with the intention to compare the intraoperative and postoperative mortality and morbidity and the postoperative quality of life between the esophagogastrostomy and the double-track anastomosis in the proximal gastrectomy for gastric cancer patients.

NCT ID: NCT02280616 Completed - Clinical trials for Eosinophilic Esophagitis

Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis

Start date: June 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy of a low and high dose of a budesonide effervescent tablet and oral viscous budesonide suspension vs. placebo for the induction treatment of active eosinophilic esophagitis.

NCT ID: NCT02227836 Completed - Clinical trials for Eosinophilic Esophagitis

Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis

EoE
Start date: August 2014
Phase: N/A
Study type: Interventional

This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.

NCT ID: NCT02204150 Completed - Clinical trials for Eosinophilic Esophagitis

Study to Image the Esophagus Using the OFDI Capsule

Start date: February 2012
Phase: N/A
Study type: Interventional

The main purpose of this research is to test the feasibility and tolerability of the tethered capsule Optical Frequency Domain Imaging (OFDI)

NCT ID: NCT02202590 Active, not recruiting - Clinical trials for Eosinophilic Esophagitis

Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus

Start date: October 2013
Phase: N/A
Study type: Interventional

The goal of this study is to test the feasibility and the tolerability of a tethered spectrally encoded confocal microscopy (SECM) capsule and to use it to image the esophagus.

NCT ID: NCT02190513 Completed - Celiac Disease Clinical Trials

Prevalence of Eosinophilic Esophagitis in Children With Celiac Disease

Start date: February 2011
Phase: N/A
Study type: Observational

Celiac disease (CD) and eosinophilic esophagitis (EE) are distinct diseases of the gastrointestinal tract with specific clinico-pathological characteristics. In recent years, in the literature, several children who underwent upper gastrointestinal endoscopy for suspected CD, which was confirmed histologically, were also found to have coexistent EE. There are reports of coexistent CD and EE. We would like to see the prevalence of EE in children with CD and the prevalence of CD in children with EE in our population, and to do so would like to review medical records. Our objectives are to determine if children with celiac disease have a high prevalence of eosinophilic esophagitis.and to determine if children with eosinophilic esophagitis have increased risk of developing celiac disease.

NCT ID: NCT02153398 Completed - Clinical trials for Zollinger-Ellison Syndrome

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Start date: June 2014
Phase: Phase 3
Study type: Interventional

The objective of this study is to assess the safety, pharmacokinetics, pharmacodynamics and efficacy of repeated once daily oral administration of D961H 10 mg and D961H 20 mg in Japanese paediatric patients aged 1 to 14 years old who either have a diagnosis of or are suspected to have gastric ulcer (GU), duodenal ulcer (DU), anastomotic ulcer (AU), non-erosive reflux esophagitis disease (NERD), reflux esophagitis (RE) or Zollinger-Ellison syndrome.

NCT ID: NCT02141711 Completed - Clinical trials for Gastroesophageal Reflux Disease (GERD)

TAK-438 - Safety, Blood Levels & Effects of Repeated Doses

TAK-438_107
Start date: October 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of TAK-438 in healthy, non-Japanese men male subjects following a randomized, double blind, placebo controlled, sequential panel, multiple-dose schedule.